Allarity Therapeutics Gelecekteki Büyüme
Future kriter kontrolleri 0/6
Allarity Therapeutics's earnings are forecast to decline at 10.2% per annum while its annual revenue is expected to grow at 115.8% per year. EPS is expected to grow by 31% per annum.
Anahtar bilgiler
-10.2%
Kazanç büyüme oranı
31.0%
EPS büyüme oranı
Biotechs kazanç büyümesi | 27.1% |
Gelir büyüme oranı | 115.8% |
Gelecekteki özkaynak getirisi | n/a |
Analist kapsamı | Low |
Son güncelleme | 02 May 2024 |
Gelecekteki son büyüme güncellemeleri
Güncelleme yok
Kazanç ve Gelir Büyüme Tahminleri
Tarih | Gelir | Kazançlar | Serbest Nakit Akışı | Faaliyetlerden Nakit | Avg. Analist Sayısı |
---|---|---|---|---|---|
12/31/2026 | N/A | -33 | N/A | N/A | 1 |
12/31/2025 | N/A | -29 | N/A | N/A | 1 |
12/31/2024 | N/A | -16 | N/A | N/A | 1 |
6/30/2024 | N/A | -13 | -16 | -16 | N/A |
3/31/2024 | N/A | -21 | -11 | -11 | N/A |
12/31/2023 | N/A | -20 | -13 | -13 | N/A |
9/30/2023 | N/A | -22 | -14 | -14 | N/A |
6/30/2023 | N/A | -23 | -13 | -13 | N/A |
3/31/2023 | N/A | -20 | -14 | -14 | N/A |
12/31/2022 | N/A | -21 | -17 | -17 | N/A |
9/30/2022 | N/A | -35 | -19 | -19 | N/A |
6/30/2022 | N/A | -29 | -18 | -18 | N/A |
3/31/2022 | N/A | -28 | -18 | -18 | N/A |
12/31/2021 | N/A | -27 | -15 | -15 | N/A |
9/30/2021 | -1 | -12 | -13 | -13 | N/A |
6/30/2021 | -1 | -12 | -11 | -11 | N/A |
3/31/2021 | N/A | -7 | -8 | -8 | N/A |
12/31/2020 | N/A | -7 | -7 | -7 | N/A |
9/30/2020 | 1 | -16 | -7 | -7 | N/A |
6/30/2020 | 1 | -17 | -8 | -8 | N/A |
3/31/2020 | 0 | -20 | -10 | -10 | N/A |
12/31/2019 | 0 | -20 | -11 | -11 | N/A |
9/30/2019 | 0 | -11 | -11 | -10 | N/A |
6/30/2019 | 1 | -8 | -9 | -9 | N/A |
3/31/2019 | 1 | -4 | -7 | -6 | N/A |
12/31/2018 | 1 | -2 | -4 | -4 | N/A |
9/30/2018 | 2 | -1 | -2 | -2 | N/A |
6/30/2018 | 1 | -1 | -2 | -2 | N/A |
3/31/2018 | 2 | -4 | N/A | 0 | N/A |
12/31/2017 | 1 | -5 | N/A | -1 | N/A |
9/30/2017 | 1 | -6 | N/A | -3 | N/A |
6/30/2017 | 1 | -6 | N/A | -3 | N/A |
3/31/2017 | 0 | -4 | N/A | -5 | N/A |
12/31/2016 | 0 | -4 | N/A | -4 | N/A |
9/30/2016 | 1 | -3 | N/A | -4 | N/A |
6/30/2016 | 1 | -2 | N/A | -4 | N/A |
3/31/2016 | 1 | -2 | N/A | -3 | N/A |
12/31/2015 | 0 | -1 | N/A | -2 | N/A |
12/31/2014 | 0 | 0 | N/A | N/A | N/A |
Analist Gelecek Büyüme Tahminleri
Kazançlar ve Tasarruf Oranları: ALLR is forecast to remain unprofitable over the next 3 years.
Kazançlar ve Piyasa: ALLR is forecast to remain unprofitable over the next 3 years.
Yüksek Büyüme Kazançları: ALLR is forecast to remain unprofitable over the next 3 years.
Gelir ve Pazar: ALLR is forecast to have no revenue next year.
Yüksek Büyüme Geliri: ALLR is forecast to have no revenue next year.
Hisse Başına Kazanç Büyüme Tahminleri
Gelecekteki Özkaynak Getirisi
Gelecekteki ROE: Insufficient data to determine if ALLR's Return on Equity is forecast to be high in 3 years time